DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,241 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,309,297 | -44.7% | 41,553 | -46.5% | 0.08% | -50.0% |
| Q2 2023 | $18,644,640 | -35.2% | 77,686 | -32.0% | 0.16% | -42.0% |
| Q1 2023 | $28,786,748 | +113.6% | 114,215 | +124.9% | 0.28% | +146.4% |
| Q4 2022 | $13,477,231 | +432.5% | 50,777 | +418.1% | 0.11% | +433.3% |
| Q3 2022 | $2,531,000 | -77.3% | 9,800 | -77.7% | 0.02% | -80.6% |
| Q2 2022 | $11,149,000 | +55.8% | 43,978 | +102.2% | 0.11% | +66.2% |
| Q4 2021 | $7,156,000 | +35.9% | 21,750 | +25.8% | 0.06% | +20.4% |
| Q3 2021 | $5,264,000 | -33.8% | 17,291 | -51.1% | 0.05% | -44.3% |
| Q1 2021 | $7,952,000 | +26.5% | 35,333 | +24.9% | 0.10% | +14.1% |
| Q4 2020 | $6,286,000 | +35.0% | 28,300 | +7.4% | 0.08% | +37.1% |
| Q2 2020 | $4,658,000 | -36.8% | 26,346 | -50.5% | 0.06% | -86.6% |
| Q1 2020 | $7,367,000 | -8.9% | 53,229 | -4.9% | 0.46% | +95.8% |
| Q3 2019 | $8,086,000 | +3446.5% | 55,986 | +3399.1% | 0.24% | +2862.5% |
| Q2 2019 | $228,000 | -80.6% | 1,600 | -82.0% | 0.01% | -80.5% |
| Q1 2019 | $1,175,000 | -67.4% | 8,900 | -73.2% | 0.04% | -74.4% |
| Q3 2018 | $3,608,000 | -24.5% | 33,200 | -31.4% | 0.16% | -38.2% |
| Q2 2018 | $4,779,000 | +0.3% | 48,431 | -0.5% | 0.26% | -27.7% |
| Q1 2018 | $4,766,000 | +949.8% | 48,677 | +895.0% | 0.36% | +867.6% |
| Q4 2017 | $454,000 | +49.8% | 4,892 | +38.7% | 0.04% | +32.1% |
| Q3 2017 | $303,000 | -79.4% | 3,527 | -79.7% | 0.03% | -81.6% |
| Q2 2017 | $1,470,000 | +170.2% | 17,416 | +173.9% | 0.15% | +176.4% |
| Q1 2017 | $544,000 | – | 6,359 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |